RoverMed BioSciences

RoverMed's nanotechnology delivers a partner's drugs right to a target no matter where a disease is in a body for hard to reach and hard to treat diseases.

  • Stage $500K in TTM Revenue
  • Industry Biotechnology
  • Location St Cloud, MN, US
  • Currency USD
  • Founded October 2016
  • Employees 5
  • Incorporation Type Other
  • Website rovermed.com

Company Summary

RoverMed's precision targeted CUSP drug delivery technology enables biologic drugs that are dependent upon cell specific delivery to target, reach, and treat diseases. Billions are spent by pharmas developing the next generation of new drugs, but most will not work unless they have a delivery technology that brings drugs right to their disease target. Our partnering strategy provides immediate revenue and we have 3 partnerships already.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free